At Enliven Therapeutics, we are an experienced and collaborative team working every day with a shared vision to help people live not only longer, but live better. Our work is guided by listening to and learning from the experiences of people living with CML.
We understand that living with CML is not just about managing a diagnosis — it’s also about things like balancing treatment with your daily life and your goals for the future.
Our approach builds on what has already been learned in CML treatment, while looking for ways to improve how therapies work and how they feel to live with — whether that means working to develop medicines with fewer side effects, greater convenience, or better long-term outcomes.
Grounded in curiosity and inspired by possibility, we are committed to supporting people living with CML.
Relcobatinib is an investigational medicine being studied for adults with chronic phase CML. It is designed to target the BCR::ABL1 protein while limiting effects on other proteins in the body. Researchers hope this may help reduce certain side effects seen with some other CML treatments. Relcobatinib is taken by mouth once daily and may be taken with or without food. Relcobatinib has not been approved for use.
This clinical trials page serves as a resource hub intended to provide educational information and resources for patients, caregivers, healthcare professionals, and the broader CML community who are participating in or interested in learning more about clinical trials.
The website does not provide medical advice, diagnosis, or treatment decisions, and should not be relied upon for medical guidance. Always seek the advice of a licensed healthcare professional with questions regarding your health or treatment options.
Explore the organizations below for education, support, and advocacy resources for people living with CML and their care partners.
Enliven Therapeutics provides this list of organizations and links as a general informational resource. Inclusion on this list does not imply endorsement of, affiliation with, or recommendation for any group or organization by Enliven Therapeutics. All listed organizations are independent of Enliven Therapeutics.